Welcome to our dedicated page for CARECLOUD SEC filings (Ticker: CCLDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) filings page on Stock Titan is designed to help investors connect the company’s regulatory disclosures with the terms and performance of this preferred security. While no specific SEC filings are listed in the provided data set, CareCloud’s public communications give a clear picture of the types of information that typically appear in its formal reports and offering documents.
For CCLDO, investors generally look to SEC filings such as registration statements, prospectuses, and periodic reports for the full legal description of the Series B Preferred Stock. These documents explain the 8.75% annual dividend rate based on a $25.00 per share liquidation preference, the cumulative nature of dividends, the monthly payment schedule, and the rights of holders in various scenarios. They also detail the issuer’s redemption options, including step-down redemption prices over time and redemption rights upon a Change of Control, as described in CareCloud’s dividend and capital markets announcements.
Company filings also typically provide context on CareCloud’s broader healthcare technology and AI business, including revenue cycle management, practice management, electronic health records, business intelligence, patient experience management, digital health, and AI initiatives. In its earnings releases and financial summaries, CareCloud has discussed revenue trends, profitability, acquisitions such as Medsphere’s hospital IT business and HFMA’s MAP App, and the role of its AI Center of Excellence. These topics are often expanded upon in Forms 10-K and 10-Q, along with risk factors, capital structure details, and discussions of preferred stock dividends and arrears.
On Stock Titan, AI-powered tools can help users interpret complex filing language related to CCLDO. Summaries can highlight key terms of the Series B Preferred Stock, such as dividend rights, redemption mechanics, and priority relative to common stock, as well as draw attention to sections of annual and quarterly reports that discuss preferred dividends, arrears plans, and financing strategies. Investors can also use filing data to cross-reference CareCloud’s press releases about dividend declarations, arrears catch-up plans, and redemption options with the formal terms set out in the Certificate of Designations and other governing documents.
By reviewing CareCloud’s SEC filings alongside its news releases, investors gain a more complete view of how the CCLDO preferred stock fits within the company’s capital structure and how its income features relate to the performance of CareCloud’s healthcare technology and AI platform.
CareCloud, Inc. director Cameron Munter reported the vesting and conversion of restricted stock units into common stock. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under CareCloud’s Amended and Restated Equity Incentive Plan, without payment by Munter.
After this transaction, Munter directly owned 195,250 shares of CareCloud common stock and 33,750 restricted stock units. The filing reflects equity-based compensation vesting rather than an open‑market purchase or sale.
CareCloud, Inc. furnished an update stating that its Board of Directors has declared monthly cash dividends on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock. These dividends are scheduled for payment in February, March and April 2026, providing continued cash distributions to holders of these preferred shares during that period. Further details, including the specific dividend terms, are contained in a press release dated January 20, 2026 that is incorporated by reference as an exhibit.